StockData
Immuneering Corp logo

Immuneering Corp (IMRX) stock

IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30
$3.46−0.06 (-1.70%)

Close on Nov 17, 2026Market cap $224.08MP/E –Yield –

Immuneering enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Immuneering's enterprise value was $180.24M on Nov 11, 2026, against $44.83M a year earlier. Over the last 5 years it ranged from -$81.54M to $250.39M, with a median of $53.58M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$180.24M+2704.0%
2025Dec 31, 2025$6.43M-55.1%
2024Dec 31, 2024$14.32M-86.5%
2023Dec 29, 2023$106.28M+919.8%
2022Dec 30, 2022$10.42M–
2021Dec 31, 2021-$15.50M–

More Immuneering figures

See a number that looks wrong?